Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
PZ HTL SA
GLOBETECH PUBLISHING

Rapidly Aging Mice Given Boost of Young Stem Cells Live Longer, Healthier

By BiotechDaily International staff writers
Posted on 23 Jan 2012
Laboratory mice bred to age rapidly appear to have grown younger after investigators injected them with stem cell-like progenitor cells derived from the muscle of young, healthy animals. Instead of becoming ill and dying early as the control mice did, animals that received the stem/progenitor cells improved their health and lived two to three times longer than expected.

These findings were published in the January 3, 2012, issue of the journal Nature Communications. Earlier studies have shown stem cell dysfunction, such as poor replication and differentiation, in a variety of tissues in old age, but it is not been determined whether that loss of function contributed to the aging process or was a result of it, explained senior investigators Johnny Huard, PhD, and Laura Niedernhofer, MD, PhD.

Dr. Huard is professor in the departments of orthopedic surgery and of microbiology and molecular genetics, University of Pittsburgh School of Medicine (Pitt; PA, USA), and director of the Stem Cell Research Center at Pitt and Children’s Hospital of Pittsburgh of UPMC. Dr. Niedernhofer is associate professor in Pitt’s department of microbiology and molecular genetics and the University of Pittsburgh Cancer Institute (UPCI).

“Our experiments showed that mice that have progeria, a disorder of premature aging, were healthier and lived longer after an injection of stem cells from young, healthy animals,” Dr. Niedernhofer said. “That tells us that stem cell dysfunction is a cause of the changes we see with aging.”

The scientists studied a stem/progenitor cell population originated from the muscle of progeria mice and discovered that compared to those from normal rodents, the cells were fewer in number, did not replicate as frequently, did not differentiate as freely into specialized cells and were impaired in their ability to regenerate damaged muscle. The same defects were discovered in the stem/progenitor cells isolated from very old mice.

“We wanted to see if we could rescue these rapidly aging animals, so we injected stem/progenitor cells from young, healthy mice into the abdomens of 17-day-old progeria mice,” Dr. Huard said. “Typically the progeria mice die at around 21 to 28 days of age, but the treated animals lived far longer--some even lived beyond 66 days. They also were in better general health.”

As the progeria mice age, they lose muscle mass in their hind limbs, hunch over, tremble, and move slowly and awkwardly. Affected mice that got a shot of stem cells just before showing the first signs of aging were more like healthy mice, and they grew almost as large. More comprehensive examination showed new blood vessel growth in the brain and muscle, even though the stem/progenitor cells were not detected in those tissues.

In fact, the cells did not migrate to any specific tissue after injection into the abdomen. “This leads us to think that healthy cells secrete factors to create an environment that help correct the dysfunction present in the native stem cell population and aged tissue,” Dr. Niedernhofer said. “In a culture dish experiment, we put young stem cells close to, but not touching, progeria stem cells, and the unhealthy cells functionally improved.”

Animals that age normally were not treated with stem/progenitor cells, but the provocative findings urge further research, she added. They speculate that it might be possible one day to suppress the biologic deteriorations associated with aging by delivering a shot of youthful vigor, especially if specific rejuvenating proteins or molecules generated by the stem cells could be identified and isolated.

Related Links:
University of Pittsburgh School of Medicine


Channels

Genomics/Proteomics

view channel
Image: Biopsy of small bowel showing celiac disease manifested by blunting of villi, crypt hyperplasia, and lymphocyte infiltration of crypts (Photo courtesy of Wikimedia Commons).

Reduced Elafin Levels Associated with Celiac Disease Bowel Inflammation

Levels of the enzyme elafin, an endogenous serine protease inhibitor, were lower in the small intestinal epithelium of patients with active celiac disease (CD) as compared to similar tissue from control patients.... Read more

Drug Discovery

view channel

Retinoic Acid Prevents Precancerous Breast Cells from Progressing to Full-Blown Cancer

Retinoic acid, a derivative of vitamin A, was found to prevent pre-cancerous breast cells from progressing to full-blown cancer but did not have any effect on breast tumor cells. Investigators at Thomas Jefferson University (Philadelphia, PA, USA) worked with a novel breast cancer model that had been developed by treating... Read more

Therapeutics

view channel

Cytokine Identified That Causes Mucositis in Cancer Therapy Patients

The action of the cytokine interleukin 1-beta (IL-1beta) has been found to underlie the onset of mucositis, a common, severe side effect of chemotherapy and irradiation of cancer patients. Mucositis occurs as a result of cell death in reaction to chemo- or radiotherapy. The mucosal lining of the mouth becomes thin, may... Read more

Business

view channel

Analytical Sciences Trade Fair Declared a Rousing Success

Organizers of this year's 24th "analytica" biosciences trade fair have reported significant increases in both the number of visitors and exhibitors compared to the 2012 event. The analytica trade fair for laboratory technology, analysis, and biotechnology has been held at the Munich (Germany) Trade Fair Center every... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.